Difference between revisions of "Part:BBa K1927000:Design"
(→Design Notes) |
|||
(6 intermediate revisions by the same user not shown) | |||
Line 7: | Line 7: | ||
===Design Notes=== | ===Design Notes=== | ||
− | |||
+ | This particular gene belongs to class B which represent metallo-β-lacatamases that contain zink in the active site. | ||
+ | We designed this biobrick without any promotor for safety reasons. As this enzyme may be resistant to several types of antibiotic the UiOslo team felt that it would be safer to design the biobrick without any promotor so that any team that wish to work with this part may use it in a controlled manner. | ||
− | + | The sequence was obtained from a clinical isolate collected from Norway and was sent to IDT for synthesizing. By designing special flanking regions the gene could easily be cloned into the shipping vector by Gibson Assembly. | |
+ | |||
+ | These are the flanking regions the gene was designed with: | ||
+ | Gctaaggatgatttctggaattcgcggccgcttctagatg<GENE>tactagtagcggccgctgcagtccggcaaaaaagggcaag | ||
− | + | If the part will be used in classical cloning with restriction enzymes be aware of the gene may naturally contain several restriction enzymes that may influence the experiment. | |
+ | |||
+ | ===Source=== | ||
+ | This part is originally from a clinical isolate of a ESBL E. Coli strain collected from a antibiotic resistance expertize center in Tromsø, Norway. The sequence has been sendt to IDT and synthesized. | ||
===References=== | ===References=== | ||
+ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1932750/ | ||
+ | http://www.sciencedirect.com/science/article/pii/S1319562X14000941#b0405 |
Latest revision as of 07:14, 14 October 2016
Beta-lacatamase enzyme called blaNDM-1
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI site found at 716
Design Notes
This particular gene belongs to class B which represent metallo-β-lacatamases that contain zink in the active site. We designed this biobrick without any promotor for safety reasons. As this enzyme may be resistant to several types of antibiotic the UiOslo team felt that it would be safer to design the biobrick without any promotor so that any team that wish to work with this part may use it in a controlled manner.
The sequence was obtained from a clinical isolate collected from Norway and was sent to IDT for synthesizing. By designing special flanking regions the gene could easily be cloned into the shipping vector by Gibson Assembly.
These are the flanking regions the gene was designed with: Gctaaggatgatttctggaattcgcggccgcttctagatg<GENE>tactagtagcggccgctgcagtccggcaaaaaagggcaag
If the part will be used in classical cloning with restriction enzymes be aware of the gene may naturally contain several restriction enzymes that may influence the experiment.
Source
This part is originally from a clinical isolate of a ESBL E. Coli strain collected from a antibiotic resistance expertize center in Tromsø, Norway. The sequence has been sendt to IDT and synthesized.
References
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1932750/ http://www.sciencedirect.com/science/article/pii/S1319562X14000941#b0405